Catalyst Pharmaceuticals' investment merits are bolstered by a favorable settlement announced on January 8. Read why I rate ...

On Wednesday, Catalyst Pharmaceuticals Inc. (NASDAQ ... Teva will not market its generic version of Firdapse in the United States before February 25, 2035, unless certain limited circumstances ...

Catalyst Pharmaceuticals settles patent litigation with Teva, delaying generic Firdapse launch until 2035. Legal actions against other defendants remain ongoing.

Despite weathering significant criticism from lawmakers and patient groups over the steep cost of its rare disease med ...

It wasn't just fact-checking that Meta scrapped from its platforms as it prepares for the second Trump administration. Meta ...

Luckily for Lawson’s squad, this was just the beginning of a long stretch in the ACC. The Blue Devils have 16 upcoming games ...

Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Read more about the events that may impact stock prices next week. Monday - January 6 ...

Plus, European companies should prepare for activists and US banks confront whether they can underwrite blacklisted companies in Hong Kong ...

A low success ratio provides us insight into the relatively limited success of the firm's product offerings. Average tenure of nine years among the longest-tenured managers at Catalyst is on par ...

Charly Triballeau/POOL/AFP via Getty Images Thomas said she believes Mangione is innocent -- framing him as a victim of the healthcare industry and justice system -- but said his case has brought ...